SCARPELLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 220
AS - Asia 55
Continente sconosciuto - Info sul continente non disponibili 1
Totale 516
Nazione #
US - Stati Uniti d'America 240
IE - Irlanda 68
UA - Ucraina 60
IT - Italia 34
HK - Hong Kong 26
VN - Vietnam 20
DE - Germania 15
FI - Finlandia 14
FR - Francia 11
RU - Federazione Russa 9
CN - Cina 8
CH - Svizzera 2
RO - Romania 2
SE - Svezia 2
AT - Austria 1
EU - Europa 1
GB - Regno Unito 1
NL - Olanda 1
TR - Turchia 1
Totale 516
Città #
Chandler 69
Dublin 68
Jacksonville 36
San Mateo 27
Hong Kong 26
Dong Ket 20
Medford 12
Princeton 12
Perugia 11
Andover 6
Beijing 5
Wilmington 5
Altamura 4
Ann Arbor 4
Foligno 4
Lawrence 4
Norwalk 4
Boardman 2
Helsinki 2
Avellino 1
Den Haag 1
Falkenstein 1
Florence 1
Izmir 1
Lausanne 1
Reghin 1
Rome 1
San Severo 1
Timisoara 1
Totale 331
Nome #
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 62
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 58
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer 51
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids 50
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses. 48
Surgical treatment of well differentiated neuroendocrine tumours of the lung 47
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. 42
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors - 42
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. 38
macro-prolactinomas:which the therapeutic space of dopamine-agonists? 37
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA 34
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors 30
Totale 539
Categoria #
all - tutte 1.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202054 3 0 9 0 9 3 10 0 11 4 2 3
2020/2021100 0 9 1 9 33 0 9 1 9 0 9 20
2021/202274 0 15 1 0 0 0 0 32 1 1 12 12
2022/2023198 12 20 7 9 21 15 0 16 82 0 10 6
2023/202448 6 3 5 2 1 1 16 0 10 0 4 0
Totale 539